M. Nechaeva
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- PARP inhibition in cancer therapy
- CAR-T cell therapy research
-
- Cancer Genomics and Diagnostics
Papers in
- Oncology 15
- Cancer Immunotherapy and Biomarkers 6
- Cancer Treatment and Pharmacology 3
- PARP inhibition in cancer therapy 3
-
- Advanced Breast Cancer Therapies 6
- Gastric Cancer Management and Outcomes 4
- Lung Cancer Treatments and Mutations 2
- Co-authors
- Hiroji Iwata (5 shared papers)Peter Schmid (5 shared papers)Sylvia Adams (3 shared papers)Luciana Molinero (3 shared papers)Véronique Dièras (3 shared papers)Sherene Loi (3 shared papers)Andreas Schneeweiß (3 shared papers)Amreen Husain (2 shared papers)
- Journals
- Annals of Oncology (8 papers)Journal of Clinical Oncology (4 papers)Cancer Research (2 papers)JNCI Journal of the National Cancer Institute (1 paper)SHILAP Revista de lepidopterología (1 paper)
- Partner nations
- RussiaUnited StatesJapan
In The Last Decade
M. Nechaeva
17 papers receiving 399 citations
M. Nechaeva's Hit Papers
Peers
Comparison fields: 5 of 41
- Oncology 326
- Cancer Research 100
- Pulmonary and Respiratory Medicine 164
- Immunology 104
- Gastroenterology 15
Countries citing papers authored by M. Nechaeva
This map shows the geographic impact of M. Nechaeva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Nechaeva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Nechaeva more than expected).
Fields of papers citing papers by M. Nechaeva
This network shows the impact of papers produced by M. Nechaeva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Nechaeva. The network helps show where M. Nechaeva may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Nechaeva, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Atezolizumab and nab-Paclitaxel in Advanced Triple-Negative Breast Cancer: Biomarker Evaluation of the IMpassion130 Study Hit paper breakdown → | 2021 | 205 |
| 2 | 2019 | 60 | |
| 3 | 2016 | 35 | |
| 4 | 2020 | 23 | |
| 5 | 2016 | 18 | |
| 6 | 2020 | 12 | |
| 7 | 2021 | 11 | |
| 8 | 2016 | 9 | |
| 9 | 2020 | 7 | |
| 10 | 2024 | 5 | |
| 11 | 2019 | 5 | |
| 12 | 2021 | 3 | |
| 13 | 2022 | 2 | |
| 14 | 2016 | 2 | |
| 15 | 2023 | 2 | |
| 16 | 2021 | 1 | |
| 17 | Efficacy and safety of extimia® (empegfilgrastim): results of a double-blind controlled phase iii study in patients with diagnosis «breast cancer» receiving myelosuppressive chemotherapy | 2015 | 1 |
About M. Nechaeva
M. Nechaeva is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Neurology and Epidemiology, having authored 17 papers that have together received 401 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), Advanced Breast Cancer Therapies (6 papers), Cancer Genomics and Diagnostics (5 papers), Gastric Cancer Management and Outcomes (4 papers), Cancer Treatment and Pharmacology (3 papers), Barrier Structure and Function Studies (3 papers), PARP inhibition in cancer therapy (3 papers) and Lung Cancer Treatments and Mutations (2 papers). The work is most often cited by research in Oncology (326 citations), Cancer Research (100 citations), Pulmonary and Respiratory Medicine (164 citations), Immunology (104 citations) and Gastroenterology (15 citations). M. Nechaeva has collaborated with scholars based in Russia, United States and Japan. Frequent co-authors include Hiroji Iwata, Peter Schmid, Sylvia Adams, Luciana Molinero, Véronique Dièras, Sherene Loi, Andreas Schneeweiß, Amreen Husain, Hope S. Rugo and Leisha A. Emens. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Cancer Research, JNCI Journal of the National Cancer Institute and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.